Product Information
TEMOZOLOMIDE 140 MG CAPSULE is a generic product labeled by Accord Healthcare Inc., priced at $11.4609 per EA under NDC 16729012953. Its NADAC has been published 152 times since Jul 21, 2021.
FDA first approved this application on Feb 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
140 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729012953
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
6/18/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201528FDA Approved
2/27/2017
TE Code
AB
On Market Since
3/7/2017
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 140 MG CAPSULE has been published 152 times since Jul 21, 2021, and over the history we have for it it has declined 17.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.4609 per EA |
|---|---|
| All-time high | $13.8362 (Jul 13, 2022) |
| All-time low | $6.5705 (Aug 21, 2024) |
| 52-week high | $11.4609 |
| 52-week low | $11.4609 |
| Median price | $11.4609 |
| Average price | $11.3901 |
| Largest weekly change | -38.7% (Aug 21, 2024) |
| Weeks tracked | 152 |
| Tracking since | Jul 21, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
-17.2%
5Y
-17.2%
All
-17.2%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 140 MG CAPSULE, manufactured by Accord Healthcare Inc., is $11.4609 per EA (NDC 16729012953), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has declined 17.2%. It has been tracked across 152 weekly CMS publications since Jul 21, 2021.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 140 MG CAPSULE?
Since Jul 21, 2021, the NADAC for TEMOZOLOMIDE 140 MG CAPSULE has ranged from a low of $6.5705 (Aug 21, 2024) to a high of $13.8362 (Jul 13, 2022), with a median of $11.4609 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 140 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $10.7251 per EA — about 6% below TEMOZOLOMIDE 140 MG CAPSULE.
Who manufactures TEMOZOLOMIDE 140 MG CAPSULE?
TEMOZOLOMIDE 140 MG CAPSULE (NDC 16729012953) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.